Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-27), Dr Sulaiman Al Habib Medical Services Group's Beta is 1.2579.
Dr Sulaiman Al Habib Medical Services Group (SAU:4013) Beta Explanation
Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.
Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)
Dr Sulaiman Al Habib Medical Services Group Beta Related Terms
Dr Sulaiman Al Habib Medical Services Group Beta Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dr Sulaiman Al Habib Medical Services Group Beta Chart
Dr Sulaiman Al Habib Medical Services Group Annual Data
For the Medical Care Facilities subindustry, Dr Sulaiman Al Habib Medical Services Group's Beta, along with its competitors' market caps and Beta data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dr Sulaiman Al Habib Medical Services Group Beta vs Healthcare Providers & Services Industry
Dr Sulaiman Al Habib Medical Services Group Beta Calculation
Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.
Dr Sulaiman Al Habib Medical Services Group (SAU:4013) has a Beta of 1.2579 as of Jun. 27, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Dr Sulaiman Al Habib Medical Services Group and its competitors.
Is Dr Sulaiman Al Habib Medical Services Group's Beta too high?
Dr Sulaiman Al Habib Medical Services Group's current Beta is 1.2579. Overall, Dr Sulaiman Al Habib Medical Services Group has a GF Score™ of 91/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dr Sulaiman Al Habib Medical Services Group's Beta compare to HCA and THC?
Dr Sulaiman Al Habib Medical Services Group's Beta of 1.2579 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Healthcare Providers & Services company?
A good Beta depends on the Healthcare Providers & Services industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Dr Sulaiman Al Habib Medical Services Group and its competitors. Dr Sulaiman Al Habib Medical Services Group's current Beta is 1.2579. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr Sulaiman Al Habib Medical Services Group stock overvalued right now?
Based on GuruFocus' analysis, Dr Sulaiman Al Habib Medical Services Group (SAU:4013) is currently considered Significantly Undervalued. The stock's GF Value™ is ﷼396.06, compared to a current price of ﷼213.80 — trading 46% below its estimated fair value. The current Beta is 1.2579. Dr Sulaiman Al Habib Medical Services Group's overall GF Score™ is 91/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Dr Sulaiman Al Habib Medical Services Group (SAU:4013), the current Beta is 1.2579 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dr Sulaiman Al Habib Medical Services Group (SAU:4013) Overvalued in 2026?
Based on GuruFocus' analysis, Dr Sulaiman Al Habib Medical Services Group stock appears to be undervalued.
The current stock price of ﷼213.80 is trading 46% below its estimated GF Value™ of ﷼396.06.
GuruFocus considers Dr Sulaiman Al Habib Medical Services Group to be Significantly Undervalued.
Key valuation signals for SAU:4013:
Beta: 1.2579
GF Value™: ﷼396.06 vs. price of ﷼213.80 (46% below fair value)
No single metric tells the full story. See the SAU:4013 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dr Sulaiman Al Habib Medical Services Group Business Description
Dr Sulaiman Al Habib Medical Services Group provides private health and ancillary services in the Kingdom and the region through the establishment, management, and operation of hospitals, medical complexes, day surgery centers, pharmaceutical facilities, and other ancillary areas, including home health care, specialized laboratories, technology and information systems, facility maintenance, tele-medicine, revenue cycle management, medical equipment maintenance, and real estate activity. The company reports in three segments: Hospitals and Healthcare Facilities, Pharmacies, and HMG Solutions and Others. The majority of revenue comes from the Hospitals and Healthcare Facilities segment.
91GF Score
Get the complete analysis for SAU:4013
Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:4013 has been successfully added to your 
